[1]

糖尿病防控评估研究小组. 2011年中国糖尿病防控蓝皮书. 2011: 4-117.
[2] Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part Ⅰ: recent advances in prevention and noninvasive management. J Am Coll Cardiol, 2007, 49(6): 631-642.  doi: 10.1016/j.jacc.2006.09.046
[3] Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol, 2000, 36(2): 355-365.  doi: 10.1016/S0735-1097(00)00732-4
[4] Nicolucci A, De Berardis G, Sacco M, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al. Diabetes Care, 2007, 30(6): e57.
[5] Hornick T, Aron DC. Preventing and managing diabetic complications in elderly patients. Cleve Clin J Med, 2008, 75(2): 153-158.  doi: 10.3949/ccjm.75.2.153
[6] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program(NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅲ). JAMA, 2001, 285(19): 2486-2497.  doi: 10.1001/jama.285.19.2486
[7] 吕卓人, 姜馨.糖尿病与心血管危险控制.中华心血管病杂志, 2001, 29(10): 637-639.  doi: 10.3760/j:issn:0253-3758.2001.10.023
[8] No authors listed. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care, 1998, 21(9): 1551-1559.  doi: 10.2337/diacare.21.9.1551
[9] Miller TD, Rajagopalan N, Hodge DO, et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J, 2004, 147(5): 890-896.  doi: 10.1016/j.ahj.2003.08.015
[10] Gaddi O, Tortorella G, Picano E, et al. Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic Type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study. Diabet Med, 1999, 16(9): 762-766.  doi: 10.1046/j.1464-5491.1999.00145.x
[11] Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab, 2005, 90(10): 5896-5903.  doi: 10.1210/jc.2005-0754
[12] Ambepityia G, Kopelman PG, Ingram D, et al. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol, 1990, 15(1): 72-77.  doi: 10.1016/0735-1097(90)90178-R
[13] Hikita H, Kurita A, Takase B, et al. Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus. Am J Cardiol, 1993, 72(2): 140-143.
[14] Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis, 2011, 104(3): 178-188.
[15] Le Feuvre C, Jacqueminet S, Barthelemy O. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients. Future Cardiol, 2011, 7(2): 183-190.
[16] Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation, 2009, 119(22): e561-587.
[17] 何作祥.心脏放射性核素显像:从诊断、危险性分层到治疗决策.中华核医学杂志, 2005, 25(1): 5-6.  doi: 10.3760/cma.j.issn.2095-2848.2005.01.001
[18] Boudreau RJ, Strony JT, duCret RP, et al. Perfusion thallium imaging of type Ⅰ diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology, 1990, 175(1): 103-105.
[19] Bell DS, Yumuk VD. Low incidence of false-positive exercise thallium 201 scintigraphy in a diabetic population. Diabetes Care, 1996, 19(2): 185-186.
[20] Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J, 1999, 137(5): 949-957.  doi: 10.1016/S0002-8703(99)70421-7
[21] Sasao H, Nakata T, Tsuchihashi K, et al. Impaired exercise-related myocardial uptake of technetium-99m-tetrofosmin in relation to coronary narrowing and diabetic state: assessment with quantitative single photon emission computed tomography. Jpn Heart J, 2001, 42(1): 29-42.  doi: 10.1536/jhj.42.29
[22] 王蒨, 王金城, 米宏志, 等.国产腺苷介入心肌灌注断层显像对心肌缺血的诊断价值.中华核医学杂志, 2006, 26(2): 81-83.  doi: 10.3760/cma.j.issn.2095-2848.2006.02.004
[23] Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation, 2000, 101(12): 1465-1478.  doi: 10.1161/01.CIR.101.12.1465
[24] 赵玉萍, 乔树宾, 宁亦斌, 等. 2型糖尿病伴胸痛的患者冠状动脉造影分析.中国糖尿病杂志, 2010, 18(11): 838-839.  doi: 10.3969/j.issn.1006-6187.2010.11.013
[25] Hernández C, Candell-Riera J, Ciudin A, et al. Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovasc Diabetol, 2011, 10(1): 9.  doi: 10.1186/1475-2840-10-9
[26] Jacqueminet S, Barthélémy O, Le Feuvre C. Screening of silent myocardial ischemia in type 2 diabetic patients: a randomized trial comparing isotopic and echocardiographic stress tests. Diabetes Care, 2010, 33(6): e79.  doi: 10.2337/dc09-2248
[27] Valensi P, Pariès J, Brulport-Cerisier V, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care, 2005, 28(11): 2722-2727.  doi: 10.2337/diacare.28.11.2722
[28] Okuyama C, Nakajima K, Hatta T, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for patients with diabetes and chronic kidney disease. Nucl Med Commun, 2011, 32(10): 913-919.  doi: 10.1097/MNM.0b013e3283495787
[29] Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease: why not?. J Am Coll Cardiol, 2006, 48(4): 761-764.  doi: 10.1016/j.jacc.2006.04.076
[30]

Perrone-Filardi P, Achenbach S, Möhlenkamp S, et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J, 2011, 32(16): 1986-1993, 1993a, 1993b.
[31] Shirani J, Dilsizian V. Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?. Curr Cardiol Rep, 2010, 12(2): 140-146.  doi: 10.1007/s11886-010-0091-z
[32] Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA, 2009, 301(15): 1547-1555.  doi: 10.1001/jama.2009.476
[33] Ruano Pérez R, Gómez-Caminero López F, Diego Domínguez M, et al. Incidence and prognostic value of ischemic heart disease in high risk cardiovascular asymptomatic diabetic patients detected by gated myocardial perfusion SPECT study. Rev Esp Med Nucl Imagen Mol, 2012, 31(2): 83-88.
[34] Charbonnel B, Bouhanick B, Le Feuvre C. SFC/ALFEDIAM(French Cardiology Society/French-speaking Association for the Study of Diabetes and Metabolic Diseases)guidelines on the management of the diabetic patient seen by a cardiologist. Recommendations, rationale, references. Arch Mal Coeur Vaiss, 2004, 97(3): 229-249.